Ameriprise’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-144,675
Closed -$5.79M 3976
2025
Q1
$5.79M Sell
144,675
-34,064
-19% -$1.33M ﹤0.01% 2201
2024
Q4
$6.84M Buy
178,739
+3,438
+2% +$137K ﹤0.01% 2114
2024
Q3
$6.98M Sell
175,301
-504,363
-74% -$21.1M ﹤0.01% 2132
2024
Q2
$26.8M Sell
679,664
-5,708
-0.8% -$222K 0.01% 1100
2024
Q1
$26.8M Buy
685,372
+2,139
+0.3% +$84.2K 0.01% 1130
2023
Q4
$27M Buy
683,233
+8,052
+1% +$294K 0.01% 1090
2023
Q3
$24.1M Buy
+675,181
New +$25.6M 0.01% 1104
2019
Q1
Sell
-11
Closed 3695
2018
Q4
$0 Hold
11
﹤0.01% 3653
2018
Q3
$0 Buy
+11
New +$286 ﹤0.01% 3724

Other funds holding BATRK

Ameriprise's BATRK Position: Q2 2025 in Review

Ameriprise sold out of Atlanta Braves Holdings Series B (BATRK) in Q2 2025, closing a stake of 144,675 shares — an estimated $5.79M sold.

Ameriprise first reported a position in BATRK in Q3 2018 and held it in 9 quarters. The position peaked at $27M in Q4 2023. 295 funds tracked by Wall St. Rank hold BATRK as of Q2 2025.

  • Ameriprise reported no remaining Atlanta Braves Holdings Series B position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 144,675 Atlanta Braves Holdings Series B shares in Q2 2025, an estimated $5.79M.
  • Ameriprise first reported a position in Atlanta Braves Holdings Series B in Q3 2018 and held it in 9 quarters.
  • Ameriprise's Atlanta Braves Holdings Series B position peaked at $27M in Q4 2023.
  • 295 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.